Janssen’s human trials for dengue virus to advance to phase II
Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered
Drugs
Pharma
Health
Medical
Pharma
Fifty-five nations facing a shortage of health workers: WHO
he WHO has identified 55 nations vulnerable to a shortfall in health workers needed to fulfil the UN’s charter for universal health coverage
Drugs
Medical
Pharma
FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four
Drugs
Pharma
Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs
Medical
Pharma
Sanofi acquires Provention Bio for $2.9 billion to boost its diabetes portfolio
Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).
Drugs
Health
Medical
Leukaemia drug effective in treating breast cancer metastatic relapse
A mice study showed promising results in treating secondary recurrence of breast cancer in lungs
Drugs
Medical
Pharma
Pfizer to buy Seagen for $43 billion to fortify cancer portfolio
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
Climate
Health
Scientists call for legally-binding global treaty to pull out space debris
As the number of satellites skyrockets, scientists have called for a legally-binding global treaty to ensure the safety of Earth's orbit from space
Health
Medical
Dim lights hours before sleep to avoid gestational diabetes mellitus
Exposure to bright lights before sleep can induce gestational diabetes mellitus in pregnant women, a study by Northwestern Medicine, an affiliate of Northwestern
Health
Medical
WHO advocates ‘social math’ to highlight global road safety
The WHO has advocated a ‘social math’ technique to magnify the issue of road safety globally for non-governmental organisations.